Harvoni 45 mg/1
ledipasvir and sofosbuvir · TABLET, FILM COATED · Gilead Sciences, Inc
No Recall History
Plain English
Harvoni is a tablet, film coated containing ledipasvir and sofosbuvir at 45 mg/1, taken oral. Manufactured by Gilead Sciences, Inc.
Key Facts
- Brand Name
- Harvoni
- Generic Name
- ledipasvir and sofosbuvir
- NDC Code (Product)
61958-1803- Manufacturer
- Gilead Sciences, Inc
- Strength
- 45 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA205834
- Drug Class
- Hepatitis C Virus NS5A Inhibitor [EPC]; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
- Marketing Start
- 08/28/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Harvoni used for?
Harvoni contains ledipasvir and sofosbuvir. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Harvoni a controlled substance?
Harvoni is not classified as a controlled substance by the DEA.
What is the generic name for Harvoni?
The generic name for Harvoni is ledipasvir and sofosbuvir. There are 1 other brand versions of ledipasvir and sofosbuvir.
What is the NDC code for Harvoni 45 mg/1?
The NDC (National Drug Code) for Harvoni 45 mg/1 is 61958-1803, listed by Gilead Sciences, Inc.